Beta
38657

Expression of human recombinase activating gene 1 and recombinase activating gene 2 (RAG1 and RAG2) in lymphoid malignancies

Thesis

Last updated: 06 Feb 2023

Subjects

-

Tags

Clinical & Chemical Pathology

Advisors

Khalil, Muna S. , Khalaf-Allah, Usama A. , Muhammad, Nahed A.

Authors

Abdel-Karim, Hanan Muhammad Sayed

Accessioned

2017-04-26 12:29:55

Available

2017-04-26 12:29:55

type

M.D. Thesis

Abstract

The process of V(D) J recombination is initiated and controlled by the enzymatic activity of the cytoplasmic proteins called recombinase which are the products of the activating two genes called RAG1 and RAG2 Both genes are expressed in immature B and T lymphocytes and activated V (D) J rearrangement in Ig and TCR genes, which are directed in cis by (RSSs) Also, they show variable expression in lymphoid malignancy of both B and T cell types that suggest their immaturity in antigenic development including all phenotypic and genotypic stages preceding (SIg) expression and T cell types not only by CD3 – TCR negative T cell types but also by CD3 – TCR positive T cell types. Mutation of the two genes account for a spectrum of combined immune deficiencies in humans.

Issued

1 Jan 2005

DOI

http://dx.doi.org/10.21473/iknito-space/32601

Details

Type

Thesis

Created At

31 Jan 2023